Medical systems around the world need our help with COVID19. After sharing an important PSA, Kellen dives into the topic of unconventional T cells. These novel immune subsets have unique functions with great therapeutic potential. In this episode, a seminal paper by Michael Crowther and colleagues is discussed. It’s titled, “Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1”.
Paper: https://www.ncbi.nlm.nih.gov/pubmed/31959982
Review: https://www.ncbi.nlm.nih.gov/pubmed/30397170
To help us spread science, please consider writing a review, sharing this episode with your friends and colleagues, or donating to support our work (Venmo @Kellen-Cavagnero).
Please reach out to us via email (kcavagnero@gmail.com) or Twitter (@KellenCavagnero) with any questions, comments, topic suggestions, etc.
